ScienceMed®

Multiparametric Magnetic Resonance Imaging and Vesical Imaging-Reporting and Data System (VI-RADS) for Bladder Cancer Diagnosis and Staging: A Guide for Clinicians from the American College of Radiology VI-RADS Steering Committee

Oncologia
Imagem de arquivo, ilustrativa — não é do estudo. Células HeLa em cultura, em microscopia de fluorescência. NIH · domínio público · Wikimedia Commons

Diretriz clínicaNível 1 · Evidência consolidadaEuropean urology31 out 202512 citações

Salvar

Resumo original em inglês

O que aconteceu

Staging of bladder cancer (BC) remains a cornerstone of treatment planning, especially in distinguishing non-muscle-invasive BC (NMIBC) from muscle-invasive BC (MIBC). Multiparametric magnetic resonance imaging (mpMRI), together with the Vesical Imaging-Reporting and Data System (VI-RADS) and its neoadjuvant chemotherapy version (nacVI-RADS), has emerged as a noninvasive, standardised tool for local staging and response assessment. Our aim was to provide urologists with a practical, up-to-date overview of bladder mpMRI and its application in diverse clinical settings.

O que encontraram

We conducted a narrative review of the literature, including original studies, meta-analyses, international guidelines, and expert consensus documents, on the role of magnetic resonance imaging (MRI) in the BC diagnostic and therapeutic pathway. KEY FINDINGS AND LIMITATIONS: mpMRI with VI-RADS improves the accuracy of preoperative staging, helps in avoiding repeat transurethral resection of bladder tumour in selected NMIBC cases, and supports decision-making in MIBC in MRI-based pathways. nacVI-RADS allows assessment of treatment responses after systemic therapies, and can potentially guide bladder-sparing approaches. Barriers include variability in access, guideline inconsistency, the reproducibility of interpretation, and limited cost-effectiveness data. However, ongoing multicentre validation efforts and standardised reporting are helping to mitigate these issues.

Por que isso importa

mpMRI, VI-RADS, and nacVI-RADS represent essential tools for enhancing risk stratification and personalising BC management in clinical urology practice. Their integration into multidisciplinary workflows has the potential to improve outcomes and reduce overtreatment.

Resumo publicado sob licença CC BY. A tradução para o português ainda não chegou a este estudo.

O estudo original

Multiparametric Magnetic Resonance Imaging and Vesical Imaging-Reporting and Data System (VI-RADS) for Bladder Cancer Diagnosis and Staging: A Guide for Clinicians from the American College of Radiology VI-RADS Steering Committee

Valeria Panebianco, Alberto Briganti, Jason A Efstathiou, Samuel J Galgano, Lyndon Luk, Valdair F Muglia, Bernadette Redd, Maarten De Rooij, Mitsuru Takeuchi, Sungmin Woo et al.

Descritores MeSH

  • Urinary Bladder Neoplasms
  • Multiparametric Magnetic Resonance Imaging
  • Transurethral Resection of Bladder
  • Humans
  • Neoplasm Invasiveness
  • Neoplasm Staging
  • Predictive Value of Tests
  • Neoadjuvant Therapy
  • Non-Muscle Invasive Bladder Neoplasms

Veja também